Prognostic impact of the serum levels of soluble CD23 in B-cell chronic lymphocytic leukemia.

E, Biondi F, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic REFERENCES leukemia: From genetics to treatment. Blood 83:10, 1994 1. Wada H, Mizutani S, Nishimura J, Usuki Y, Kohsaki M, Komai 5. Nucifora G, Rowley JD: The AML1 and ETO genes in acute M, Kaneko H, Sakamoto S, Delia D, Kanamaru A, Kakishita E: myeloid leukemia with a t(8;21). Leuk Lymphoma 14:353, 1994 Establishment and molecular characterization of a novel leukemic 6. Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock cell line with Philadelphia chromosome expressing p230 BCR/ABL C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar fusion protein. Cancer Res 55:3192, 1995 S, Dalla-Favera R, Chaganti RSK: Rearrangement of the bcl-6 gene 2. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino as a prognosic marker in diffuse large-cell lymphoma. N Engl J Med R, Meloni G, Saglio G, Salvatore F, Rotoli B: Neutrophilic-chronic 331:74, 1994 myeloid leukemia: A distinct disease with a specific molecular 7. Cervantes F, Urbano Ispizua A, Villamor N, Feliu E, Milla marker (BCR/ABL with c3a2 junction). Blood 88:2410, 1996 F, Lopez Guillermo A, Ribera JM, Granada J, Vives Corrons JL, 3. Melo JV: The diversity of BCR/ABL fusion proteins and their Monserrat E, Rozman C: Ph-positive chronic myeloid leukemia relationship to leukemia phenotype. Blood 88:2375, 1996 mimicking essential thrombocythemia and terminating into mega4. Grignani Fr, Fagioli M, Alcalay L, Longo L, Pandolfi PP, Donti karyoblastic blastic crisis. Leukemia 7:327, 1993